Litigation Details for Purdue Pharmaceutical v. Actavis Elizabeth LLC (Fed. Cir. 2015)
✉ Email this page to a colleague
Purdue Pharmaceutical v. Actavis Elizabeth LLC (Fed. Cir. 2015)
| Docket | ⤷ Try a Trial | Date Filed | 2015-05-13 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Patents | 6,024,981; 6,200,604; 6,264,981; 6,264,987; 6,383,471; 6,514,531; 6,589,556; 6,720,001; 6,759,059; 6,761,910; 7,658,945; 7,682,628; 8,242,131; 8,252,809 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Purdue Pharmaceutical v. Actavis Elizabeth LLC
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Biologic Drugs cited in Purdue Pharmaceutical v. Actavis Elizabeth LLC
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Purdue Pharmaceutical v. Actavis Elizabeth LLC (Fed. Cir. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-07-13 | 43 | 5,965,162 A 10/1999 Fuisz et al. 6,024,981 A 2/2000 Khankari et al. …are U.S. Patent No. 8,242,131 (the “’131 patent”), U.S. Patent No. 7,682,628 (the “’628 patent”), and … multiple patents for its advances; including U.S. Patent Nos. 8,242,131 (the “’131 Patent”); 8,252,809… The ’809 patent is a patent indicated for the treatment of MOTN insomnia. The ’131 patent is directed…’628 Patent, February 17, 2004; 2) for the ’131 Patent, May 25, 2005; and 3) for the ’809 Patent, May | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
